Antifungal Efficacy during Candida krusei Infection in Non-Conventional Models Correlates with the Yeast In Vitro Susceptibility Profile
Figure 3
Interaction between C. krusei and haemocytes.
(A) Changes in haemocyte density during C. krusei infection. The haemolymph of infected larvae with C. neoformans, C. albicans SC5314, C. krusei ATCC 6258, CL8053 and CL80317 clinical isolates and PBS was collected and the concentration of haemocytes was estimated using a haemocytometer (B). Phagocytosis percentage of C. neoformans, C. albicans SC5314, C. krusei ATCC 6258, CL8053 and CL80317 clinical isolates. Asterisks denote differences statistically significant (p<0.05).